EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blocking group 2 innate lymphoid cell activation and macrophage M2 polarization: potential therapeutic mechanisms in ovalbumin-induced allergic asthma by calycosin

Chunyan Tian, Qi Liu, Xiaoyu Zhang, Zhuying Li

BMC Pharmacology and Toxicology · 2024

DOI: 10.1186/s40360-024-00751-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Pharmacology and Toxicology, 2024. Verfasst von Chunyan Tian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China. Hauptthemen laut MEDLINE: Asthma, Ovalbumin, Macrophages, Isoflavones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Youth Project of National Natural Science Foundation of China, the "Double First-class" Discipline Outstanding Youth Fund of Heilongjiang University of Chinese Medicine, the General Program of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Calycosin, a flavonoid compound extracted from Astragalus membranaceus , has shown anti-asthma benefits in house dust mite-induced asthma. Recent studies have suggested that innate-type cells, including group 2 innate lymphoid cells (ILC2s) and macrophages, serve as incentives for type 2 immunity and targets for drug development in asthma. This work focuses on the effects of calycosin on the dysregulated ILC2s and macrophages in allergic asthma.

Methods

In vivo, the asthmatic mouse model was established with ovalbumin (OVA) sensitization and challenge, and calycosin was intraperitoneally administered at doses of 20 and 40 mg/kg. In vivo, mouse primary ILC2s were stimulated with interleukin (IL)-33 and mouse RAW264.7 macrophages were stimulated with IL-4 and IL-13 to establish the cell models. Cells were treated with calycosin at doses of 5 and 10 µM.

Results

In vivo, we observed significantly reduced numbers of eosinophils, neutrophils, monocyte macrophages and lymphocytes in the bronchoalveolar lavage fluid (BALF) of OVA-exposed mice with 40 mg/kg calycosin. Histopathological assessment showed that calycosin inhibited the airway inflammation and remodeling caused by OVA. Calycosin markedly decreased the up-regulated IL-4, IL-5, IL-13, IL-33, and suppression tumorigenicity 2 (ST2) induced by OVA in BALF and/or lung tissues of asthmatic mice. Calycosin repressed the augment of arginase 1 (ARG1), IL-10, chitinase-like 3 (YM1) and mannose receptor C-type 1 (MRC1) levels in the lung tissues of asthmatic mice. In vivo, calycosin inhibited the IL-33-induced activation as well as the increase of IL-4, IL-5, IL-13 and ST2 in ILC2s. Calycosin also repressed the increase of ARG1, IL-10, YM1 and MRC1 induced by IL-4 and IL-13 in RAW264.7 macrophages. In addition, we found that these changes were more significant in 40 mg/kg calycosin treatment than 20 mg/kg calycosin.

Conclusions

Collectively, this study showed that calycosin might attenuate OVA-induced airway inflammation and remodeling in asthmatic mice via preventing ILC2 activation and macrophage M2 polarization. Our study might contribute to further study of asthmatic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaOvalbuminMacrophagesIsoflavonesLymphocytesMice, Inbred BALB CAnimalsMiceRAW 264.7 CellsImmunity, InnateFemaleAnti-Asthmatic AgentsBronchoalveolar Lavage FluidLungInterleukin-33

Stichwörter der Autor:innen

AsthmaCalycosinGroup 2 innate lymphoid cellsMacrophages

Substanzen

7,3'-dihydroxy-4'-methoxyisoflavoneOvalbuminIsoflavonesAnti-Asthmatic AgentsInterleukin-33

Autor:innen und Institutionen

  • Department of Respiratory Medicine, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Department of Graduate, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Department of Respiratory Medicine, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China. lizhuying_6808@163.com.

Förderung

  • the Youth Project of National Natural Science Foundation of China
  • the "Double First-class" Discipline Outstanding Youth Fund of Heilongjiang University of Chinese Medicine
  • the General Program of National Natural Science Foundation of China
  • the "Double First-class" Discipline Development Support Fund of Heilongjiang University of Chinese Medicine
  • the Reserve Leader Funding Project of Leading Talent Echelon of Heilongjiang Province

Zitieren

APA

Tian, C., Liu, Q., Zhang, X., & Li, Z. (2024). Blocking group 2 innate lymphoid cell activation and macrophage M2 polarization: potential therapeutic mechanisms in ovalbumin-induced allergic asthma by calycosin. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-024-00751-9

Vancouver

Tian C, Liu Q, Zhang X, Li Z. Blocking group 2 innate lymphoid cell activation and macrophage M2 polarization: potential therapeutic mechanisms in ovalbumin-induced allergic asthma by calycosin. BMC Pharmacology and Toxicology. 2024. doi:10.1186/s40360-024-00751-9

BibTeX
@article{Tian2024,
  author = {Tian, Chunyan and Liu, Qi and Zhang, Xiaoyu and Li, Zhuying},
  title = {Blocking group 2 innate lymphoid cell activation and macrophage M2 polarization: potential therapeutic mechanisms in ovalbumin-induced allergic asthma by calycosin},
  journal = {BMC Pharmacology and Toxicology},
  year = {2024},
  doi = {10.1186/s40360-024-00751-9}
}
Kostenlos starten →